• Introduced
    Mar 09, 2023
  • Passed Senate
    May 03, 2023
  • Passed House
  • Became Law
SB 2212
Texas Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.
Last Action See all actions
House • May 06, 2023: Referred to Public Health
Latest Bill Text See all bill texts

Summary

Comments on SB 2212

Tweets

Whip Lists

Sponsors
Votes
Looks like there aren't any voting records available at this moment.
Actions
  • May 06, 2023 | House
    • Read first time
    • Referred to Public Health
  • May 04, 2023 | House
    • Received from the Senate
  • May 03, 2023 | Senate
    • Placed on local & uncontested calendar
    • Laid before the Senate
    • Read 2nd time & passed to engrossment
    • Vote recorded in Journal
    • Three day rule suspended
    • Record vote
    • Read 3rd time
    • Passed
    • Record vote
    • Reported engrossed
  • Apr 25, 2023 | Senate
    • Reported favorably as substituted
    • Recommended for local & uncontested calendar
    • Committee report printed and distributed
  • Apr 20, 2023 | Senate
    • Considered in public hearing
    • Vote taken in committee
  • Apr 19, 2023 | Senate
    • Scheduled for public hearing on . . . 04/19/2023
    • Considered in public hearing
    • Testimony taken in committee
    • Left pending in committee
  • Mar 22, 2023 | Senate
    • Read first time
    • Referred to Health & Human Services
  • Mar 09, 2023 | Senate
    • Received by the Secretary of the Senate
    • Filed